Latest California Healthline Stories
Congress Rakes In Millions From Drugmakers
In the first six months of this year, pharmaceutical firms and their trade groups donated almost $4 million to the campaigns of a variety of senators and House members.
Legislation To End Surprise Medical Bills Has High Public Support — In Both Parties
Almost 80% of Americans support efforts in Congress to protect patients from bills that come from doctors or hospitals that were outside their insurance network.
States Pass Record Number Of Laws To Reel In Drug Prices
So far this year, 33 states have enacted more than 50 measures to address drug prices, affordability and access. Congress is eyeing the efforts to see what works.
Estados promulgan leyes para frenar los precios de los medicamentos
En lo que va del año, 33 han promulgado un récord de 51 leyes para confrontar los precios, la accesibilidad y el acceso a los medicamentos.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Cómo sería el “fenomenal” plan de salud que promete Trump
El presidente ha mencionado en varias oportunidades un plan de salud, sin ofrecer muchos detalles. Sin embargo, un documento de 2018 deja entrever algunas de sus ideas centrales.
Trump Promises ‘Phenomenal’ Health Plan. What Might That Mean?
In the background, advisers weigh the risks of rolling out a comprehensive health care proposal. Peering into the crystal ball, here’s a glimpse of what could be included in a GOP plan.
Starving Seniors: How California’s Aging Are Falling Through The Cracks
One in 12 older Californians struggle to find enough food to eat while the federal program intended to help hasn’t kept pace with the graying population. That’s worse than the national average, with particularly high numbers in the San Jose and Riverside areas.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Pharma Cash Rolls Into Congress To Defend An Embattled Industry
Congress has a variety of reforms in mind that could roil the drugmaking business and potentially slash prices.